Your browser doesn't support javascript.
loading
High D-dimer level is associated with increased 15-d and 3 months mortality through a more central localization of pulmonary emboli and serious comorbidity.
Klok, F A; Djurabi, R Karami; Nijkeuter, M; Eikenboom, H C J; Leebeek, F W G; Kramer, M H H; Kaasjager, K; Kamphuisen, P W; Büller, H R; Huisman, M V.
Afiliação
  • Klok FA; Section of Vascular Medicine, Department of General Internal Medicine - Endocrinology, Leiden University Medical Centre, Leiden, The Netherlands. f.a.klok@lumc.nl
Br J Haematol ; 140(2): 218-22, 2008 Jan.
Article em En | MEDLINE | ID: mdl-18028485
ABSTRACT
High D-dimer levels are predictors of death in patients with pulmonary embolism (PE), as are more proximally located, larger emboli. The direct link between these three has not yet been described. A cohort of 674 consecutive patients with confirmed PE was studied. Patients were followed up for 3 months. D-dimer levels were measured only in patients with an unlikely clinical probability (n = 262). The odds ratio (OR) for death of all variables was calculated. Multivariate analysis was performed to identify independent risk factors for mortality. The best predictive D-dimer cut-off point for mortality was a concentration >3000 ng/ml FEU (OR 7.29). High D-dimer levels were correlated with active malignancy and age over 65 years, both being indicators of 3-month mortality. High D-dimer levels were also correlated with centrally located pulmonary emboli and 15-d mortality. The combination of high D-dimer levels and central emboli increased early mortality risk by 2.2. High D-dimer levels in patients with an unlikely clinical probability were associated with fatal outcome after PE. Centrally located pulmonary emboli were associated with higher D-dimer levels and worse 15-d mortality. Active malignancy, being an inpatient at time of diagnosis and age over 65 years were associated with higher D-dimer levels and worse 3-month survival.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Embolia Pulmonar / Produtos de Degradação da Fibrina e do Fibrinogênio Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Br J Haematol Ano de publicação: 2008 Tipo de documento: Article País de afiliação: Holanda
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Embolia Pulmonar / Produtos de Degradação da Fibrina e do Fibrinogênio Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Br J Haematol Ano de publicação: 2008 Tipo de documento: Article País de afiliação: Holanda